Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WOK vs AZI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AZI Captures Overall Composite Edge (39.9 SELL vs 25.6 SELL), While WOK Leads 3–1 on Growth & Valuation Pillars

AZI Overall Winner 6-Pillar Tally: WOK 3 – 1 AZI (2 Tie) Matrix Metrics: WOK 4 – 4 AZI

As of Nov 16, 2026, Autozi Internet Technology (Global) Ltd. Class A (AZI) captures the overall head-to-head institutional edge over WORK Medical Technology Group LTD Class A (WOK) on higher Unified Composite conviction (39.9/100 SELL vs. 25.6/100 SELL) after splitting the core matrix 4–4 (led by Growth & Scale), while WOK wins 3–1 across the 6-pillar growth and valuation breakdown. WOK trades at $1.23 (N/M Forward P/E, -41.7% operating margin) versus AZI at $0.52 (N/M Forward P/E, -46.9% operating margin).

  • Growth vs. Quality Trade-Off: AZI earns the overall head-to-head edge with a stronger Unified Composite Score (39.9/100 SELL vs. WOK 25.6/100 SELL) and 6.90β · 94% Vol risk profile, whereas WOK leads top-line expansion (+19.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although AZI compares more favorably head-to-head, both WOK (25.6/100 SELL) and AZI (39.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile AZI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WOK vs AZI
WOK NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap $5.4M
TTM Revenue $11M
Forward P/E N/M
Beta / 30D Vol 38.49β · 153% Vol
Unified Composite Score
25.6 / 100 SELL
Tech 5.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $1.13 · SMA50: $1.47
AZI NASDAQ Head-to-Head Winner
Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Services-Automotive Repair, Services & Parking
$0.52
-14.94% 1D
Market Cap $40.8M
TTM Revenue $72M
Forward P/E N/M
Beta / 30D Vol 6.90β · 94% Vol
Unified Composite Score
39.9 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.2%), weak momentum, RSI 20
RSI-14: 20.0 · SMA20: $0.74 · SMA50: $0.99

6-Pillar Scorecard Institutional Category Breakdown (WOK 3 – 1 AZI)

Columns: Metric · WOK · AZI
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.5x 0.6x
2. Growth & Scale AZI
Revenue Growth (YoY) +19.1% -63.0%
Earnings Growth (YoY) -95.0% +0.0%
TTM Revenue (USD) $11M $72M
Market Cap $5.4M $40.8M
3. Profitability & Quality WOK
Gross Margin 17.0% 1.4%
Operating Margin -41.7% -46.9%
Net Profit Margin -41.9% -51.8%
Return on Equity (ROE) -19.2% 0.0%
4. Balance Sheet & Cash Flow WOK
Cash Generation (TTM) -$3.4M EBITDA -$34M EBITDA
Cash Flow Margin -31.4% EBITDA Mgn -46.7% EBITDA Mgn
Net Cash / Leverage $1855.16 Book/Sh · -19.2% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat WOK
OpEx & R&D Intensity 58.7% of Rev ($6.3M) 48.3% of Rev ($35M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Auto & Truck Dealerships Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WOK (4) vs AZI (4)
Institutional Metric WOK AZI Criterion Row Edge
Market Capitalization
Scale
$5.4M $40.8M Larger Scale AZI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+19.1% -63.0% Higher Growth WOK
Operating Margin (TTM)
Profitability
-41.7% -46.9% Higher Margin WOK
Net Profit Margin
Profitability
-41.9% -51.8% Higher Margin WOK
Return on Equity (ROE)
Capital Efficiency
-19.2% 0.0% Higher ROE AZI
52-Week Range Position
Momentum
16% ($0–$7) 7% ($0–$7) Stronger Trend WOK
Beta / 30D Volatility
Risk Regime
38.49β · 153% Vol 6.90β · 94% Vol Lower Realized Risk AZI
Unified Institutional Score
Composite Signal
25.6 / 100 (SELL) 39.9 / 100 (SELL) Higher Composite AZI
Trailing 12M Revenue (USD)
Operating Scale
$11M $72M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.0% 1.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$3.4M EBITDA ($1855.16 Book/Sh · -19.2% ROE) -$34M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WOK +62.04 pp
WOK: +12.84% · AZI: -49.2%
3M Horizon WOK +10.41 pp
WOK: -44.09% · AZI: -54.5%
6M Horizon WOK +282.48 pp
WOK: +223.68% · AZI: -58.8%
1Y Horizon AZI +610.1 pp
WOK: -72.05% · AZI: +538.05%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs AZI. Trailing 12-month operating profitability (WOK -41.7% vs AZI -46.9%) and valuation multiples (WOK N/M vs AZI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

WOK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$11M
Gross Margin17.0%
Op. Margin-41.7%
ROE / Fwd P/E-19.2% · N/M
AZI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$72M
Gross Margin1.4%
Op. Margin-46.9%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WOK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WOK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AZI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AZI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WOK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $5.4M market capitalization and -41.7% operating margin.
OpEx & R&D Reinvestment 58.7% of Rev ($6.3M)
90D Engineering Disclosures 0 Published
AZI Moat Profile Cyclical / Execution-Driven Positioning
Auto & Truck Dealerships Operator
Competes within the Auto & Truck Dealerships value chain with $40.8M market capitalization and -46.9% operating margin.
OpEx & R&D Reinvestment 48.3% of Rev ($35M)
90D Engineering Disclosures 0 Published

Investor FAQ WOK vs AZI Key Questions & Quantitative Answers

As of Nov 16, 2026, Autozi Internet Technology (Global) Ltd. Class A (AZI) captures the overall head-to-head institutional edge over WORK Medical Technology Group LTD Class A (WOK) on higher Unified Composite conviction (39.9/100 SELL vs. 25.6/100 SELL) after splitting the core matrix 4–4 (led by Growth & Scale), while WOK wins 3–1 across the 6-pillar growth and valuation breakdown. WOK trades at $1.23 (N/M Forward P/E, -41.7% operating margin) versus AZI at $0.52 (N/M Forward P/E, -46.9% operating margin). Growth vs. Quality Trade-Off: AZI earns the overall head-to-head edge with a stronger Unified Composite Score (39.9/100 SELL vs. WOK 25.6/100 SELL) and 6.90β · 94% Vol risk profile, whereas WOK leads top-line expansion (+19.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although AZI compares more favorably head-to-head, both WOK (25.6/100 SELL) and AZI (39.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile AZI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AZI leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with AZI at -63.0% YoY revenue growth and +0.0% YoY earnings growth on $72M TTM revenue (1.4% gross margin, -46.9% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $72M for AZI. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 48.3% of Rev ($35M) (0 disclosures) for AZI.

WOK and AZI trade at balanced relative valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas AZI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-46.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus AZI (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, AZI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (6.90β · 94% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

WORK Medical Technology Group LTD Class A Ordinary Shares (WOK) Research Suite

Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares (AZI) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.